CSI Market
Sign In | Register

Cytodyn inc (CYDY) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CYDY Annual Cash Flow →
The data below summarizes Cytodyn inc's cash flow activity from May 31 2025 to May 31 2026, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(May 31 2026)
12 Months 		(Feb 28 2026) (Nov 30 2025) (Aug 31 2025) (May 31 2025)
Operating Activities
Income-86.88
Depreciation & amortization0.02
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventory Write-down0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation1.63
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Extinguishment Of Debt Amount-
Gain Loss On Non Recourse Debt-
Debt Conversion Converted Instrument Amount6.75
Stock Issued-
Gain Loss On Derivative Instruments Net Pretax-
Amortization Of Debt Issuance Costs-
Interest Expense On Conversion Inducement-
Cost Of Goods And Services Sold Depreciation And Amortization-
Induced Conversion Of Convertible Debt Expense-
Interest Expense Related To Accretion Of Convertible Notes Payable-
Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost-
Adjustment To Reconcile Net Loss To Net Cash Used In Operating Activities Litigation Settlement-
Loss On Induced Conversion Of Debt-
Gains Losses On Restructuring Of Debt-
Income taxes0.00
Gain (Loss) on Sale of Derivatives0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities17.87
Increase (Decrease) in Accrued Salaries0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense-4.01
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities54.12
Discontinued operations0.00
Net Cash flow from Operating Activities-17.25
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Proceeds from Collection of Long-term Loans to Related Parties0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.14
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock1.05
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net16.29
Capital Contributions By President-
Proceeds From Notes Payable To Related Parties-
Payments On Notes Payable To Related Parties-
Proceeds From Stock Deposits-
Payments For Deferred Offering Costs-
Proceeds From Issuance Of Stock Of Business Units Acquisition-
Payment Of Indebtedness-
Proceeds From Exercise Of Warrants And Stock Options-
Proceeds From Issuance Of Common Stock And Warrants15.32
Proceeds From Warrant Tender Offer Held In Trust-
Proceeds From Warrant Tender Offers-
Paymentsforwarranttenderofferheldintrust-
Proceeds From Stock Option Excercises-
Payments of Ordinary Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities17.20
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-17.25
Total Cash Flow-0.05
4 historic quarters locked

Sign in to unlock the full Cytodyn inc cash flow history.

Sign In Create Free Account

About Cytodyn Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-040687

Figures are derived from filed reports and may be restated. Historical data is subject to revision.